NasdaqCM - Delayed Quote USD

First Wave BioPharma, Inc. (FWBI)

2.9900 +0.1400 (+4.91%)
At close: 4:00 PM EDT
2.9300 -0.06 (-2.01%)
After hours: 4:59 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
15,770.8270
15,770.8270
12,678.0660
56,704.9000
26,432.7680
Operating Income
-15,770.8270
-15,770.8270
-12,678.0660
-56,704.9000
-26,432.7680
Net Non Operating Interest Income Expense
-19.9320
-19.9320
-7.4640
-10.0620
-5,840.1300
Other Income Expense
-4.2240
-4.2240
-1,944.1120
-1,822.8870
-398.5680
Pretax Income
-15,794.9830
-15,794.9830
-14,629.6420
-58,537.8490
-32,671.4660
Net Income Common Stockholders
-16,103.1110
-16,103.1110
-14,973.0690
-84,518.5880
-41,732.3380
Diluted NI Available to Com Stockholders
-16,103.1110
-16,103.1110
-14,973.0690
-84,518.5880
-41,732.3380
Basic EPS
-47.88
--
-416.94
-39.77k
-56.32k
Diluted EPS
-47.88
--
-416.94
-39.77k
-56.32k
Basic Average Shares
336.3420
--
35.9120
2.1250
0.7410
Diluted Average Shares
336.3420
--
35.9120
2.1250
0.7410
Total Operating Income as Reported
-15,770.8270
-15,770.8270
-12,678.0660
-59,056.8880
-26,432.7680
Total Expenses
15,770.8270
15,770.8270
12,678.0660
56,704.9000
26,432.7680
Net Income from Continuing & Discontinued Operation
-15,794.9830
-15,794.9830
-14,629.6420
-58,537.8490
-32,671.4660
Normalized Income
-15,794.9830
-15,794.9830
-12,918.2710
-56,185.8610
-32,061.4680
Interest Income
2.5310
2.5310
8.4150
1.1730
0.4840
Interest Expense
22.4630
22.4630
15.8790
11.2350
5,840.6140
Net Interest Income
-19.9320
-19.9320
-7.4640
-10.0620
-5,840.1300
EBIT
-15,772.5200
-15,772.5200
-14,613.7630
-58,526.6140
-26,830.8520
EBITDA
-15,743.2460
-15,743.2460
-14,584.4920
-57,984.3590
-26,265.5070
Reconciled Depreciation
29.2740
29.2740
29.2710
542.2550
565.3450
Net Income from Continuing Operation Net Minority Interest
-15,794.9830
-15,794.9830
-14,629.6420
-58,537.8490
-32,671.4660
Total Unusual Items Excluding Goodwill
--
--
-1,711.3710
-2,351.9880
-609.9980
Total Unusual Items
--
--
-1,711.3710
-2,351.9880
-609.9980
Normalized EBITDA
-15,743.2460
-15,743.2460
-12,873.1210
-55,632.3710
-25,655.5090
12/31/2020 - 10/11/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ENSC Ensysce Biosciences, Inc.
0.5850
+10.65%
 
PBLA Panbela Therapeutics, Inc.
0.4061
+6.92%
 
KPRX Kiora Pharmaceuticals, Inc.
0.5097
+3.60%
 
MLTX MoonLake Immunotherapeutics
41.71
+1.93%
 
PXMD PaxMedica, Inc.
0.2288
+10.53%
 
CPMV Mosaic ImmunoEngineering, Inc.
0.4000
+5.50%
 
PALI Palisade Bio, Inc.
6.22
-7.30%
 
QNRX Quoin Pharmaceuticals, Ltd.
0.7894
+2.16%
 
ONCO Onconetix, Inc.
0.1134
+6.98%
 
SPRC SciSparc Ltd.
1.2500
0.00%